Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation

被引:25
|
作者
Zhang, Jin [1 ]
Gao, Zhanguo [1 ]
Ye, Jianping [1 ]
机构
[1] Louisiana State Univ, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA 70808 USA
基金
美国国家卫生研究院;
关键词
Insulin resistance; Inflammation; Obesity; Liver; TNF-alpha; PROTEIN-KINASES PHOSPHORYLATE; INSULIN-RECEPTOR SUBSTRATE-1; MAMMALIAN TARGET; IN-VITRO; P70(S6K); RAPAMYCIN; SITES; RESISTANCE; PATHWAY; IRS-1;
D O I
10.1016/j.bbadis.2013.06.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
S6K (ribosomal S6 kinase p70, p70S6K) activation requires phosphorylation at two stages. The first phosphorylation is independent of insulin stimulation and mediated by an unknown kinase. The second phosphorylation is mediated by mTOR in insulin dependent manner. In this study, we identified JNIC1 (c-Jun N-terminal kinase 1) as a kinase in the first phosphotylation. S6K protein was phosphorylated by JNIC1 at S411 and S424 in the carboxyl terminal autoinhibitory domain. The phosphotylation was observed in kinase assay with purified S6K as a substrate, and in cells after JNK1 activation by TNF-alpha or MEKK1 expression. The phosphorylation was detected in JNK2 null cells, but not in JNK1 null cells after TNF-a treatment. When JNK1 activation was inhibited by MKK7 knockdown, the phosphorylation was blocked in cells. The phosphorylation led to S6K protein degradation in NF-kappa B deficient cells. The degradation was blocked by inhibition of proteasome activity with MG132. In wide type cells, the phosphorylation did not promote S6K degradation when IKK2 (IKK beta, I kappa B kinase beta) was activated. Instead, the phosphorylation allowed S6K activation by mTOR, which stabilizes S6K protein. In IKK2 null cells or cells treated by IKK2 inhibitor, the phosphorylation led to S6K degradation. These data suggest that S6K is phosphorylated by JNKI and the phosphorylation makes S6K protein unstable in the absence of IKK2(1(2 activation. This study provides a mechanism for regulation of S6K protein stability. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1980 / 1988
页数:9
相关论文
共 50 条
  • [21] S6K1: reducing the RiSKs of aging
    Bedford, David C.
    DISEASE MODELS & MECHANISMS, 2010, 3 (3-4) : 123 - 124
  • [22] PI3K/AKT and mTOR/p70S6K1 Signaling Pathways in Human Cancer
    Jiang, Bing-Hua
    CURRENT CANCER DRUG TARGETS, 2013, 13 (03) : 233 - 233
  • [23] Sulforaphane induces apoptosis in adipocytes via Akt/p70s6k1/Bad inhibition and ERK activation
    Yao, Anjun
    Shen, Yingzhuo
    Wang, Anshi
    Chen, Shiyong
    Zhang, Huiqin
    Chen, Fen
    Chen, Zhongming
    Wei, Hua
    Zou, Zuquan
    Shan, Yujuan
    Zhang, Xiaohong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 465 (04) : 696 - 701
  • [24] SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis
    Li, Heng
    Tian, Zhufang
    Qu, Yiping
    Yang, Qi
    Guan, Haixia
    Shi, Bingyin
    Ji, Meiju
    Hou, Peng
    ONCOGENE, 2019, 38 (03) : 345 - 359
  • [25] Characterization of S6K2, a novel kinase homologous to S6K1
    Lee-Fruman, KK
    Kuo, CJ
    Lippincott, J
    Terada, N
    Blenis, J
    ONCOGENE, 1999, 18 (36) : 5108 - 5114
  • [26] SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis
    Heng Li
    Zhufang Tian
    Yiping Qu
    Qi Yang
    Haixia Guan
    Bingyin Shi
    Meiju Ji
    Peng Hou
    Oncogene, 2019, 38 : 345 - 359
  • [27] Protein intake is essential to increase S6K1 phosphorylation following exercise
    Koopman, Rene
    Zorenc, Antoine H. G.
    Pennings, Bart
    van Loon, Luc J. C.
    FASEB JOURNAL, 2007, 21 (06): : A837 - A837
  • [28] Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1
    Chen, Gui-hao
    Xu, Chuan-sheng
    Zhang, Jie
    Li, Qing
    Cu, He-he
    Li, Xiang-dong
    Chang, Li-ping
    Tang, Rui-jie
    Xu, Jun-yan
    Tian, Xia-qiu
    Huang, Pei-sen
    Xu, Jun
    Jin, Chen
    Yang, Yue-jin
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [29] MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1
    Shi, Zhu-mei
    Wang, Jing
    Yan, Zhiping
    You, Yong-ping
    Li, Chong-yong
    Qian, Xu
    Yin, Yu
    Zhao, Peng
    Wang, Ying-ying
    Wang, Xie-feng
    Li, Ming-na
    Liu, Ling-Zhi
    Liu, Ning
    Jiang, Bing-Hua
    PLOS ONE, 2012, 7 (03):
  • [30] The mTOR/p70S6K1 signaling pathway in renal fibrosis of children with immunoglobulin A nephropathy
    Xu, Yuanyuan
    Ling, Yihong
    Yang, Fan
    Deng, Jiong
    Rong, Liping
    Jiang, Mengjie
    Jiang, Xiaoyun
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2017, 18 (03)